![Thomas Burns](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Burns
Chief Executive Officer at
GLAUKOS CORPORATION
Net worth: 183 M $ as of 2026-05-30
Profile
Thomas William Burns was the founder of DOSE Medical Corp., founded in 2009, where the title held was Chairman from 2015 to 2019.
Current jobs include Chairman & Chief Executive Officer at Glaukos Corp.
since 2022, and Independent Director at Pulmonx Corp.
since 2020.
Former jobs include President, Chief Operating Officer & Director at Oldtech, Inc.; Independent Director at Avedro, Inc. from 2018 to 2019; VP-Global Strategy & GM-Refractive Surgery at Bausch & Lomb, Inc. from 1998 to 2000; Entrepreneur-in-Residence at Versant Venture Management LLC; and Senior Vice President & General Manager at Chiron Vision Corp.
from 1990 to 1997.
Education includes undergraduate studies at Yale University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GLAUKOS CORP 3.09% | 2026-04-01 | 1,772,726 ( 3.09% ) | 183 M $ | 2026-05-30 |
PULMONX CORP. 0.27% | 2026-06-04 | 113,399 ( 0.27% ) | 187 108 $ | 2026-05-30 |
Thomas Burns active positions
| Companies | Position | Start |
|---|---|---|
| GLAUKOS CORPORATION | Chief Executive Officer | 2000-12-31 |
| PULMONX CORPORATION | Director/Board Member | 2020-08-31 |
Former positions of Thomas Burns
| Companies | Position | End |
|---|---|---|
| AVEDRO, INC. | Director/Board Member | 2019-08-05 |
DOSE Medical Corp.
 DOSE Medical Corp. Medical DistributorsDistribution Services Develops multiple micro-invasive, bioerodible, sustained-release drug delivery platforms | Chief Executive Officer | 2015-05-31 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Corporate Officer/Principal | 1999-12-31 |
Chiron Vision Corp. | Corporate Officer/Principal | 1996-12-31 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Corporate Officer/Principal | - |
Training of Thomas Burns
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
47
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Pulmonx Corp.
 Pulmonx Corp. Medical SpecialtiesHealth Technology Develops and manufactures zephyr endobronchial valves for the treatment of emphysema | Health Technology |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
DOSE Medical Corp.
DOSE Medical Corp. Medical DistributorsDistribution Services Develops multiple micro-invasive, bioerodible, sustained-release drug delivery platforms | Distribution Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Chiron Vision Corp. |
- Stock Market
- Insiders
- Thomas Burns
